Immunogen Inc (DELISTED) (IMGN:DL)
31.23
0.00 (0.00%)
USD |
NASDAQ |
Feb 13, 16:00
Immunogen Shareholders Equity (Quarterly): 561.60M for Sept. 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 561.60M |
June 30, 2023 | 490.84M |
March 31, 2023 | 121.92M |
December 31, 2022 | 155.83M |
September 30, 2022 | 178.01M |
June 30, 2022 | 249.83M |
March 31, 2022 | 306.47M |
December 31, 2021 | 325.59M |
September 30, 2021 | 77.09M |
June 30, 2021 | 68.46M |
March 31, 2021 | 94.12M |
December 31, 2020 | 89.57M |
September 30, 2020 | -42.89M |
June 30, 2020 | -24.52M |
March 31, 2020 | -4.103M |
December 31, 2019 | -76.12M |
September 30, 2019 | -86.22M |
June 30, 2019 | -68.17M |
March 31, 2019 | -27.60M |
December 31, 2018 | 10.97M |
September 30, 2018 | 46.89M |
June 30, 2018 | 89.19M |
March 31, 2018 | -36.31M |
December 31, 2017 | -17.90M |
September 30, 2017 | -111.30M |
Date | Value |
---|---|
June 30, 2017 | -173.23M |
March 31, 2017 | -167.53M |
September 30, 2016 | -122.54M |
June 30, 2016 | -82.30M |
March 31, 2016 | -41.14M |
December 31, 2015 | -16.69M |
September 30, 2015 | 11.61M |
June 30, 2015 | 35.10M |
March 31, 2015 | 59.67M |
December 31, 2014 | 77.47M |
September 30, 2014 | 58.97M |
June 30, 2014 | 75.70M |
March 31, 2014 | 97.93M |
December 31, 2013 | 130.04M |
September 30, 2013 | 119.44M |
June 30, 2013 | 121.85M |
March 31, 2013 | 139.00M |
December 31, 2012 | 136.00M |
September 30, 2012 | 157.31M |
June 30, 2012 | 83.89M |
March 31, 2012 | 100.93M |
December 31, 2011 | 115.34M |
September 30, 2011 | 123.77M |
June 30, 2011 | 139.97M |
March 31, 2011 | 64.82M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-76.12M
Minimum
Dec 2019
561.60M
Maximum
Sep 2023
160.73M
Average
108.02M
Median
Shareholders Equity (Quarterly) Benchmarks
AbbVie Inc | 6.032B |
Pfizer Inc | 92.29B |
Johnson & Johnson | 70.16B |
Merck & Co Inc | 44.50B |
Cerevel Therapeutics Holdings Inc (DELISTED) | 564.46M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 822.10M |
Total Liabilities (Quarterly) | 260.50M |
Debt to Equity Ratio | 0.1284 |
Current Ratio | 5.695 |
Net Debt Paydown Yield | -0.34% |